Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 47 (11%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 375 (84%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (17%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DICLOFENAC EC | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2017-04-10 | 2017-04-27 | 6274 |
| DICLOFENAC EC | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2019-03-16 | 2024-03-02 | 78849 |
| AMOXICILLIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-01-20 | 2020-04-21 | 103704 |
| AMOXICILLIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-10-20 | 2024-02-14 | 172266 |
| AMOXICILLIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-07-18 | 2023-11-06 | 198944 |
| AMOXICILLIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2024-01-30 | 2024-04-23 | 217816 |
| AMOXICILLIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-11-08 | 2024-02-14 | 173943 |
| AMOXICILLIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-07-18 | 2023-09-05 | 198913 |
| ALENDRONATE | 70MG | TABLET | Resolved | 2017-06-06 | 2018-05-26 | 12091 |
| ALENDRONATE | 70MG | TABLET | Resolved | 2017-09-13 | 2018-05-26 | 21985 |
| ALENDRONATE | 70MG | TABLET | Resolved | 2021-11-17 | 2022-07-06 | 149505 |
| ALENDRONATE | 70MG | TABLET | Resolved | 2022-01-19 | 2022-07-06 | 153051 |
| OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-11-27 | 2018-12-11 | 30725 |
| OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-03-27 | 2022-08-30 | 79597 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-09-13 | 2018-11-16 | 21992 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-03-27 | 2024-03-02 | 79600 |
| OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-06-06 | 2018-09-28 | 12095 |
| OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-09-13 | 2018-09-28 | 21989 |
| OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-01-14 | 2024-02-27 | 103271 |
| ROPINIROLE | 0.25MG | TABLET | Resolved | 2017-09-27 | 2017-10-16 | 23677 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
| TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |